title: Treatment of gram-positive peritonitis in peritoneal dialysis patients: cefazolin or vancomycin?
authors.affiliation: Department of Nephrology, Centre Hospitalier de l'Université de Montréal, Campus Notre-Dame, Québec, Canada. renee.levesque@wanadoo.fr
authors.forename: Renée
authors.initials: R
authors.lastname: Lévesque
authors.forename: Claude
authors.initials: C
authors.lastname: Lemieux
authors.forename: Michel
authors.initials: M
authors.lastname: Laverdière
authors.forename: Vincent
authors.initials: V
authors.lastname: Pichette
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002437:Cefazolin / Q000627:therapeutic use*; D005500:Follow-Up Studies; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D010530:Peritoneal Dialysis / Q000009:adverse effects; D010538:Peritonitis / Q000209:etiology / Q000382:microbiology*; D012189:Retrospective Studies; D014640:Vancomycin / Q000627:therapeutic use*
chemical_list: D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002437:Cefazolin